ZIVO · Zivo Bioscience, Inc. · Debt
$0.67
At close · Nov 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued.”View the 10-Q filed Nov 14, 2025
Market Cap
$16.53M
Shares
3.89M
Volume · Nov 27
226.8K
Avg daily vol (21 sessions)
42.21K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of convertible debt | 2025-09-30 | USD 236,513 | 10-Q filed 2025-11-14 |
| Current portion of notes payable | 2025-09-30 | USD 139,223 | 10-Q filed 2025-11-14 |
| Noncurrent notes payable | 2025-09-30 | USD 11,663 | 10-Q filed 2025-11-14 |
| Operating lease liabilities | 2025-09-30 | USD 285,837 | 10-Q filed 2025-11-14 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Other notes payable | 2025-09-30 | USD 146,459 | 10-Q filed 2025-11-14 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.